ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $362.49M | $332.69M | $912.30M | $1.12B | $923.34M | $856.62M | $661.13M | $539.38M | $512.74M |
| Cash & equivalents | $85.31M | $55.03M | $96.58M | $123.44M | $139.06M | $90.03M | $65.06M | $47.92M | $70.50M |
| Current assets | $205.25M | $180.72M | $612.69M | $726.91M | $402.75M | $562.15M | $410.19M | $283.75M | $300.19M |
| Total liabilities | $587.11M | $590.80M | $341.26M | $373.15M | $319.24M | $392.52M | $352.86M | $336.89M | $287.74M |
| Current liabilities | $21.00M | $22.80M | $78.31M | $105.20M | $113.81M | $109.79M | $88.02M | $98.05M | $89.92M |
| Long-term debt | $342000.00 | $336000.00 | — | — | — | — | — | — | — |
| Shareholder equity | $-224.62M | $-258.11M | $571.04M | $743.27M | $603.99M | $464.17M | $308.40M | $202.71M | $218.79M |
| Retained earnings | $-249.42M | $-295.91M | $-365.48M | $-511.61M | $-718.89M | $-919.08M | $-1.14B | $-1.30B | $-1.36B |
| Accounts receivable | $5.58M | $4.81M | $12.68M | $10.05M | $17.41M | $40.06M | $37.97M | $41.73M | $50.37M |
| Inventory | $4.79M | $7.84M | $9.07M | $14.06M | $19.26M | $14.45M | $14.45M | $8.44M | $9.82M |
| Goodwill | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M |